345 related articles for article (PubMed ID: 15661874)
21. Invariant chain and the MHC class II cytoplasmic domains regulate localization of MHC class II molecules to lipid rafts in tumor cell-based vaccines.
Dolan BP; Phelan TP; Ilkovitch D; Qi L; Wade WF; Laufer TM; Ostrand-Rosenberg S
J Immunol; 2004 Jan; 172(2):907-14. PubMed ID: 14707062
[TBL] [Abstract][Full Text] [Related]
22. The protease inhibitor cystatin C is differentially expressed among dendritic cell populations, but does not control antigen presentation.
El-Sukkari D; Wilson NS; Hakansson K; Steptoe RJ; Grubb A; Shortman K; Villadangos JA
J Immunol; 2003 Nov; 171(10):5003-11. PubMed ID: 14607896
[TBL] [Abstract][Full Text] [Related]
23. Immunochemical localisation of cathepsin S, cathepsin L and MHC class II-associated p41 isoform of invariant chain in human lymph node tissue.
Zavasnik-Bergant V; Sekirnik A; Golouh R; Turk V; Kos J
Biol Chem; 2001 May; 382(5):799-804. PubMed ID: 11517933
[TBL] [Abstract][Full Text] [Related]
24. Cathepsin S inhibitor prevents autoantigen presentation and autoimmunity.
Saegusa K; Ishimaru N; Yanagi K; Arakaki R; Ogawa K; Saito I; Katunuma N; Hayashi Y
J Clin Invest; 2002 Aug; 110(3):361-9. PubMed ID: 12163455
[TBL] [Abstract][Full Text] [Related]
25. Cathepsin L maturation and activity is impaired in macrophages harboring M. avium and M. tuberculosis.
Nepal RM; Mampe S; Shaffer B; Erickson AH; Bryant P
Int Immunol; 2006 Jun; 18(6):931-9. PubMed ID: 16636015
[TBL] [Abstract][Full Text] [Related]
26. Degradation of mouse invariant chain: roles of cathepsins S and D and the influence of major histocompatibility complex polymorphism.
Villadangos JA; Riese RJ; Peters C; Chapman HA; Ploegh HL
J Exp Med; 1997 Aug; 186(4):549-60. PubMed ID: 9254653
[TBL] [Abstract][Full Text] [Related]
27. Expression of cathepsins B, L, S, and D by gastric epithelial cells implicates them as antigen presenting cells in local immune responses.
Barrera C; Ye G; Espejo R; Gunasena S; Almanza R; Leary J; Crowe S; Ernst P; Reyes VE
Hum Immunol; 2001 Oct; 62(10):1081-91. PubMed ID: 11600214
[TBL] [Abstract][Full Text] [Related]
28. The proteolytic environment involved in MHC class II-restricted antigen presentation can be modulated by the p41 form of invariant chain.
Fineschi B; Sakaguchi K; Appella E; Miller J
J Immunol; 1996 Oct; 157(8):3211-5. PubMed ID: 8871612
[TBL] [Abstract][Full Text] [Related]
29. Differential expression of CLIP:MHC class II and conventional endogenous peptide:MHC class II complexes by thymic epithelial cells and peripheral antigen-presenting cells.
Farr A; DeRoos PC; Eastman S; Rudensky AY
Eur J Immunol; 1996 Dec; 26(12):3185-93. PubMed ID: 8977321
[TBL] [Abstract][Full Text] [Related]
30. Intestinal epithelial cells use two distinct pathways for HLA class II antigen processing.
Hershberg RM; Framson PE; Cho DH; Lee LY; Kovats S; Beitz J; Blum JS; Nepom GT
J Clin Invest; 1997 Jul; 100(1):204-15. PubMed ID: 9202073
[TBL] [Abstract][Full Text] [Related]
31. Antigen processing and presentation in human muscle: cathepsin S is critical for MHC class II expression and upregulated in inflammatory myopathies.
Wiendl H; Lautwein A; Mitsdörffer M; Krause S; Erfurth S; Wienhold W; Morgalla M; Weber E; Overkleeft HS; Lochmüller H; Melms A; Tolosa E; Driessen C
J Neuroimmunol; 2003 May; 138(1-2):132-43. PubMed ID: 12742663
[TBL] [Abstract][Full Text] [Related]
32. Lysosomal cysteine and aspartic proteases are heterogeneously expressed and act redundantly to initiate human invariant chain degradation.
Costantino CM; Hang HC; Kent SC; Hafler DA; Ploegh HL
J Immunol; 2008 Mar; 180(5):2876-85. PubMed ID: 18292509
[TBL] [Abstract][Full Text] [Related]
33. Cathepsin S required for normal MHC class II peptide loading and germinal center development.
Shi GP; Villadangos JA; Dranoff G; Small C; Gu L; Haley KJ; Riese R; Ploegh HL; Chapman HA
Immunity; 1999 Feb; 10(2):197-206. PubMed ID: 10072072
[TBL] [Abstract][Full Text] [Related]
34. Class II MHC/peptide complexes are released from APC and are acquired by T cell responders during specific antigen recognition.
Patel DM; Arnold PY; White GA; Nardella JP; Mannie MD
J Immunol; 1999 Nov; 163(10):5201-10. PubMed ID: 10553040
[TBL] [Abstract][Full Text] [Related]
35. The ins and outs of MHC class II-mediated antigen processing and presentation.
Roche PA; Furuta K
Nat Rev Immunol; 2015 Apr; 15(4):203-16. PubMed ID: 25720354
[TBL] [Abstract][Full Text] [Related]
36. Differential regulation of cathepsin S and cathepsin L in interferon gamma-treated macrophages.
Beers C; Honey K; Fink S; Forbush K; Rudensky A
J Exp Med; 2003 Jan; 197(2):169-79. PubMed ID: 12538657
[TBL] [Abstract][Full Text] [Related]
37. DM, but not cathepsin L, is required to control an aerosol infection with Mycobacterium tuberculosis.
Nepal RM; Vesosky B; Turner J; Bryant P
J Leukoc Biol; 2008 Oct; 84(4):1011-8. PubMed ID: 18591414
[TBL] [Abstract][Full Text] [Related]
38. Subepithelial myofibroblasts are novel nonprofessional APCs in the human colonic mucosa.
Saada JI; Pinchuk IV; Barrera CA; Adegboyega PA; Suarez G; Mifflin RC; Di Mari JF; Reyes VE; Powell DW
J Immunol; 2006 Nov; 177(9):5968-79. PubMed ID: 17056521
[TBL] [Abstract][Full Text] [Related]
39. Identification and characterization of major histocompatibility complex class II compartments in cortical thymic epithelial cells.
Arudchelvan Y; Nishimura Y; Tokuda N; Sawada T; Ueyama Y; Fukumoto T
Anat Rec A Discov Mol Cell Evol Biol; 2003 Sep; 274(1):798-806. PubMed ID: 12923890
[TBL] [Abstract][Full Text] [Related]
40. Cathepsins B and D are dispensable for major histocompatibility complex class II-mediated antigen presentation.
Deussing J; Roth W; Saftig P; Peters C; Ploegh HL; Villadangos JA
Proc Natl Acad Sci U S A; 1998 Apr; 95(8):4516-21. PubMed ID: 9539769
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
